Fundraising FoxOmniox
San Francisco, US · Delaware corporation · 3 known investors
Find your way into Omniox
Sign up to see every warm intro you have to Omniox
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Omniox team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Omniox is an IND-stage biotherapeutics company developing its H-NOX platform into OMX oxygen delivery biologics that carry oxygen to hypoxic tissues where low oxygen levels drive disease. The company aims to treat a range of unmet medical needs by restoring normal tissue function.
Founders & leadership
Board
JS
Jeffrey S. SambergBoard director
LM
MM
Mitchell MutzBoard director
JW
John WesleyBoard director
AS
Ajit ShahBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$35.4M disclosed across 3 of 4 rounds · 2014–2026
▶$24.1MraisedMar 2026 · 93 investors · Other TechnologyRule 506(b)
▶$24.1MraisedMar 2026 · 93 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey S. SambergDirector
- Laurence MartonDirector
- Mitchell MutzDirector
- Jonathan WingerExecutive Officer, Director
- Offering amount
- $28.1M
- Amount sold
- $24.1M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.7MraisedJul 2016 · 29 investors · BiotechnologyRule 506(b)
▶$4.7MraisedJul 2016 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen CaryExecutive Officer, Director
- John WesleyDirector
- Jeff SambergDirector
- Ajit ShahDirector
- Offering amount
- $8.5M
- Amount sold
- $4.7M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.6MraisedJun 2014 · 21 investors · BiotechnologyRule 506(b)
▶$6.6MraisedJun 2014 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John WesleyDirector
- Jeff SambergDirector
- Stephen CaryExecutive Officer, Director
- Ajit ShahDirector
- Offering amount
- $6.6M
- Amount sold
- $6.6M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Omniox.
Frequently asked questions
- What does Omniox do?
- Omniox is an IND-stage biotherapeutics company developing its H-NOX platform into OMX oxygen delivery biologics that carry oxygen to hypoxic tissues where low oxygen levels drive disease. The company aims to treat a range of unmet medical needs by restoring normal tissue function.
- Who founded Omniox?
- Omniox was founded by Jonathan Winger, Stephen Cary.
- Who are Omniox's investors?
- Omniox's investors include EcoR1 Capital, Plug and Play Ventures, Wavemaker Three-Sixty Health.
- How much funding has Omniox raised?
- Omniox has disclosed $35.4M raised across 3 of its 4 known rounds.
- Where is Omniox headquartered?
- Omniox is headquartered in San Francisco, US.